Avalign Technologies Inc. | | | off-label or unapproved promotion of medical products | 2019 | USAO | $9,500,000 |
St. Francis Hospital, Inc. | Bon Secours Mercy Health | healthcare services | HHS civil monetary penalties | 2004 | HHSOIG | $9,491,191 |
Endo Pharmaceuticals | Endo International | pharmaceuticals | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Walmart | Walmart | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,500,000 |
K-VA-T Food Stores Inc. dba Food City | K-VA-T Food Stores | retailing | Controlled Substances Act violation | 2024 | DOJ_CIVIL | $8,488,378 |
Woodfield Pharmaceutical LLC | | | Controlled Substances Act violation | 2022 | USAO | $8,400,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
CVS Pharmacy Inc. | CVS Health | retailing | Controlled Substances Act violation | 2016 | USAO | $8,000,000 |
The Waters of Aurora Park and The Waters of Orchard Park | | | nursing home violation | 2003 | NY-AG | $8,000,000 |
McLaren Health Care Corporation | McLaren Health Care | healthcare services | Controlled Substances Act violation | 2021 | USAO | $7,750,000 |
GeneScience Pharmaceutical Company | | | off-label or unapproved promotion of medical products | 2010 | USAO | $7,500,000 |
Allergan Ltd. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
Rite Aid Corporation | Rite Aid | retailing | Controlled Substances Act violation | 2024 | DOJ_CIVIL | $7,500,000 |
United Shockwave Services | | | HHS civil monetary penalties | 2010 | HHSOIG | $7,359,500 |
Advanced OrthoPro Inc. | | | HHS civil monetary penalties | 2021 | HHSOIG | $7,191,731 |
Saratoga Center for Rehabilitation and Skilled Nursing Care | | | nursing home violation | 2023 | NY-AG | $7,100,000 |
Steward Holy Family Hospital | Steward Health Care | healthcare services | HHS civil monetary penalties | 2020 | HHSOIG | $6,952,847 |
InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
AMITA Health Mercy Medical Center, AMITA Health Saints Mary, and Elizabeth Medical Center | | | HHS civil monetary penalties | 2022 | HHSOIG | $6,232,196 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Virginia Hospital Center | | | HHS civil monetary penalties | 2021 | HHSOIG | $6,050,628 |
Inspire Pharmaceuticals | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
PharMerica Drug Systems Inc. | KKR & Co. | private equity (including portfolio companies) | HHS civil monetary penalties | 2005 | HHSOIG | $5,975,000 |
Inspire Pharmaceuticals Inc. | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | USAO | $5,900,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Barrington Terrace of Boynton Beach et al. | | | HHS civil monetary penalties | 2021 | HHSOIG | $5,764,501 |
AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
Image Plastic Surgery, LLC dba Park Avenue Stem Cell | | | off-label or unapproved promotion of medical products | 2021 | NY-AG | $5,190,933 |
Medicus Laboratories, LLC | | | HHS civil monetary penalties | 2014 | HHSOIG | $5,000,000 |
Spectranetics Corporation | Royal Philips | diversified | off-label or unapproved promotion of medical products | 2009 | FDA | $5,000,000 |
Rite Aid Corporation | Rite Aid | retailing | Controlled Substances Act violation | 2009 | DOJ_CIVIL | $5,000,000 |
Rite Aid Corporation | Rite Aid | retailing | Controlled Substances Act violation | 2009 | DEA | $5,000,000 |
CVS Pharmacy Inc. | CVS Health | retailing | Controlled Substances Act violation | 2017 | USAO | $5,000,000 |
InSite Diagnostic Health Care | | | HHS civil monetary penalties | 2022 | HHSOIG | $4,934,727 |
Providence Saint John | Providence | healthcare services | HHS civil monetary penalties | 2022 | HHSOIG | $4,902,537 |
Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,800,000 |
Amedisys, Inc. | Amedisys | healthcare services | HHS civil monetary penalties | 2016 | HHSOIG | $4,677,642 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249 |
University of Texas Southwestern Medical Center | University of Texas | miscellaneous services | Controlled Substances Act violation | 2021 | DEA | $4,500,000 |
University of Texas Southwestern Medical Center | University of Texas | miscellaneous services | Controlled Substances Act violation | 2021 | USAO | $4,500,000 |
Insys Therapeutics Inc. | | | off-label or unapproved promotion of medical products | 2017 | IL-AG | $4,450,000 |
Pikeville Medical Center | | | Controlled Substances Act violation | 2022 | USAO | $4,394,600 |
Sovah Health | | | Controlled Substances Act violation | 2022 | USAO | $4,360,000 |
Sentara Healthcare | Sentara Healthcare | healthcare services | HHS civil monetary penalties | 2021 | HHSOIG | $4,330,218 |
University of Michigan Health System | Michigan Medicine | healthcare services | Controlled Substances Act violation | 2018 | USAO | $4,300,000 |
Spivack, Inc. | | | Controlled Substances Act violation | 2022 | USAO | $4,100,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
St. Joseph Mercy-Oakland | Trinity Health | healthcare services | HHS civil monetary penalties | 2005 | HHSOIG | $4,000,000 |
Value Drug Inc. | | | Controlled Substances Act violation | 2014 | USAO | $4,000,000 |
Rite Aid Corporation | Rite Aid | retailing | Controlled Substances Act violation | 2018 | USAO | $4,000,000 |
Medicis Pharmaceutical Corporation | Bausch Health | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000 |
Next Step Healthcare, LLC | | | nursing home violation | 2024 | MA-AG | $4,000,000 |
Atricure Inc. | AtriCure | medical equipment and supplies | off-label or unapproved promotion of medical products | 2010 | FDA | $3,760,000 |
MedLab Inc. | | | HHS civil monetary penalties | 2023 | HHSOIG | $3,729,502 |
GlaxoSmithKline | GSK plc | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
Kindred Nursing Centers L.P. | Apollo Global Management | private equity (including portfolio companies) | nursing home violation | 2004 | KY-AG | $3,684,605 |
Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
HealthONE Radiation Therapy at Red Rocks LLC | | | HHS civil monetary penalties | 2021 | HHSOIG | $3,569,646 |
CVS Pharmacy Inc. | CVS Health | retailing | Controlled Substances Act violation | 2016 | USAO | $3,500,000 |
H.D. Smith Wholesale Drug Co. | | | Controlled Substances Act violation | 2017 | WV-AG | $3,500,000 |
People's Pharmacy, Inc. | | | Controlled Substances Act violation | 2023 | USAO | $3,500,000 |
Paradigm Diagnostics, Inc. | | | HHS civil monetary penalties | 2022 | HHSOIG | $3,432,729 |
Carefusion Corporation | Becton Dickinson | medical equipment and supplies | off-label or unapproved promotion of medical products | 2019 | USAO | $3,300,000 |
Brookdale Senior Living, Inc. | Brookdale Senior Living | healthcare services | nursing home violation | 2022 | CA-MULTI | $3,250,000 |
Humana, Inc. | Humana | healthcare services | Medicare Parts C and D Enforcement Action | 2015 | CMS | $3,100,900 |
Darien Pharmacy | | | Controlled Substances Act violation | 2019 | USAO | $3,100,000 |
Palomar Health | | | HHS civil monetary penalties | 2020 | HHSOIG | $3,084,315 |
Saint Peter's University Hospital and New Brunswick Cardiac Cath Lab | | | HHS civil monetary penalties | 2020 | HHSOIG | $3,040,205 |
Safeway division of Albertson's Companies | Albertsons Companies | retailing | Controlled Substances Act violation | 2017 | DEA | $3,000,000 |
PharmScript of KS, LLC | | | Controlled Substances Act violation | 2022 | USAO | $3,000,000 |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | pharmaceuticals | HHS civil monetary penalties | 2007 | HHSOIG | $2,950,000 |
McElroy Pharmacy, Inc. | | | Controlled Substances Act violation | 2021 | USAO | $2,900,000 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Express Scripts, Inc. | Cigna | healthcare services | Controlled Substances Act violation | 2012 | DEA | $2,750,000 |
AlixaRx, LLC | | | Controlled Substances Act violation | 2021 | USAO | $2,750,000 |
Premier Hospice and Palliative Care, LLC | | | HHS civil monetary penalties | 2014 | HHSOIG | $2,674,895 |
W.A. Foote Memorial Hospital d/b/a Allegiance Health | | | HHS civil monetary penalties | 2015 | HHSOIG | $2,635,441 |
Envision Pharmaceutical Services | Rite Aid | retailing | Medicare Parts C and D Enforcement Action | 2015 | CMS | $2,596,700 |
Beverly Enterprises, Inc. | Fillmore Capital Partners | private equity (including portfolio companies) | nursing home violation | 2002 | CA-AG | $2,586,927 |
Miami-Luken | | | Controlled Substances Act violation | 2016 | WV-AG | $2,500,000 |
UnitedHealthcare Medicare & Retirement | UnitedHealth Group | healthcare services | Medicare Parts C and D Enforcement Action | 2016 | CMS | $2,498,850 |
Woodfield Distribution, LLC | | | Controlled Substances Act violation | 2023 | USAO | $2,475,000 |
Hartford Hospital | Hartford HealthCare | healthcare services | HHS civil monetary penalties | 2017 | HHSOIG | $2,469,374 |
Ascension Sacred Heart Pensacola | Ascension Health | healthcare services | HHS civil monetary penalties | 2023 | HHSOIG | $2,418,057 |
Centera Bioscience, d/b/a Nootropics Depot | | | off-label or unapproved promotion of medical products | 2023 | USAO | $2,400,000 |
Visiting Nurse Association and Hospice of Vermont and New Hampshire, Inc. | | | HHS civil monetary penalties | 2021 | HHSOIG | $2,389,706 |
Suncoast Dermatology and Skin Surgery Center et al. | | | HHS civil monetary penalties | 2020 | HHSOIG | $2,320,119 |
Massachusetts General Hospital | Mass General Brigham | healthcare services | Controlled Substances Act violation | 2015 | USAO | $2,300,000 |
Extendicare Homes, Inc. | | | nursing home violation | 2005 | WI-AG | $2,273,485 |
Novel Laboratories Inc. | Lupin Limited | pharmaceuticals | Controlled Substances Act violation | 2024 | DEA | $2,250,000 |
Vital Care EMS, Inc. | | | HHS civil monetary penalties | 2020 | HHSOIG | $2,213,516 |
Neiswanger Management Services, LLC | | | nursing home violation | 2018 | MD-AG | $2,200,000 |
UnitedHealth Group, Inc. | UnitedHealth Group | healthcare services | Medicare Parts C and D Enforcement Action | 2012 | CMS | $2,175,000 |
Dartmouth-Hitchcock Health et al. | Dartmouth-Hitchcock Health | healthcare services | HHS civil monetary penalties | 2022 | HHSOIG | $2,171,075 |
Oswego Hospital | Oswego Health | healthcare services | HHS civil monetary penalties | 2009 | HHSOIG | $2,134,027 |
The Arc of Anchorage | | | HHS civil monetary penalties | 2018 | HHSOIG | $2,049,392 |
Argus Health Systems, Inc. | | | HHS civil monetary penalties | 2014 | HHSOIG | $2,029,210 |
West Valley Imaging Limited Partnership | | | HHS civil monetary penalties | 2009 | HHSOIG | $2,000,000 |
St.Vincent Hospital | Ascension Health | healthcare services | Controlled Substances Act violation | 2007 | DEA | $2,000,000 |